News

Romosozumab, used in osteoporosis treatment, may offer dual benefits by also reducing the risk for osteoarthritis, notably knee osteoarthritis.
Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access ...
Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to ...
SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.
A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved by insurers, including Medicare, with many of them being processed ...
Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
The shoulder has a wide range of motion making it the most mobile joint. But because of this flexibility, it's not very stable and easily injured.
Whether at home, in the gym, or outdoors–the resistance band is a versatile tool for effectively training muscles anytime and ...
WEIGHT loss drugs can sound like a magical quick fix to overeating and constant hunger pangs. But not everyone is eligible ...
Pacira BioSciences (PCRX) announced a strategic collaboration with Johnson & Johnson (JNJ) MedTech to significantly expand the market reach of ...
You’re considering new options for managing chronic pain, and PRP injections might just offer the relief you’re seeking. This innovative therapy taps into your body’s natural healing power, offering ...